Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Current Taxes (2022 - 2025)

Oramed Pharmaceuticals' Current Taxes history spans 4 years, with the latest figure at $3.3 million for Q4 2025.

  • For Q4 2025, Current Taxes changed N/A year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, changed N/A, while the annual FY2025 figure was $3.3 million, N/A changed from the prior year.
  • Current Taxes reached $3.3 million in Q4 2025 per ORMP's latest filing, down from $3.5 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $3.8 million in Q1 2025 to a low of $11000.0 in Q4 2022.
  • Average Current Taxes over 4 years is $1.2 million, with a median of $11000.0 recorded in 2022.
  • Peak YoY movement for Current Taxes: changed 0.0% in 2023, then soared 34336.36% in 2025.
  • A 4-year view of Current Taxes shows it stood at $11000.0 in 2022, then changed by 0.0% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then surged by 29772.73% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Current Taxes are $3.3 million (Q4 2025), $3.5 million (Q3 2025), and $344000.0 (Q2 2025).